Company: NIVFW
Filing Date: 2025-06-03
Form Type: 424B3
Source: 0001213900-25-050825
Chunk: 47

Company: NewGenIvf Group Ltd
Filing Date: 2025-06-03
Form: 424B3
Chunk 47
---
 may fluctuate significantly and may not fully reflect the underlying performance of NewGenIvf’s business.

NewGenIvf’s interim
and annual results of operations, including the levels of NewGenIvf’s revenues, expenses, net (loss)/income and other key metrics,
may vary significantly in the future due to a variety of factors, some of which are outside of NewGenIvf’s control, and period-to-period
comparisons of NewGenIvf’s operating results may not be meaningful, especially given NewGenIvf’s limited operating history.
Accordingly, the results for any one fiscal half year or any one fiscal year are not necessarily an indication of future performance.
Fluctuations in interim and/or annual financial results may adversely affect the price of NewGenIvf’s ordinary shares. Factors
that may cause fluctuations in NewGenIvf’s interim and annual financial results include:

| ● | NewGenIvf’s                                                                          
 ability to attract new customers and maintain relationships with existing customers; |

| ● | changes                                                                                     
 in NewGenIvf’s products and services offered and introduction of new services and products; |

| ● | the                                                                                            
 amount and timing of operating expenses related to marketing and the maintenance and expansion 
 of NewGenIvf’s business, operations and infrastructure;                                        |

| ● | general                                       
 economic, industry and market conditions; and |

| ● | the                                                                                         
 timing of expenses related to the development or acquisition of technologies or businesses. |

<div align='center'>30</div>

If the estimates and assumptions NewGenIvf uses to determine the size of the target markets for its services are inaccurate, its future growth rate may be impacted and its business would be harmed.

Market opportunity estimates and growth forecasts are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. Market opportunity estimates and growth forecasts included in this prospectus, including those NewGenIvf has generated itself, are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate, including the risks described in this prospectus. Even if the markets in which NewGenIvf competes achieve the forecasted growth, its business could fail to grow at similar rates, if at all.

NewGenIvf’s estimates of the market opportunity for its services are based on the assumption that the purpose-built, data-driven and disruptive fertility services platform with the plan design NewGenIvf offers will be attractive to clients. Clients may pursue alternatives or may not see the value